Register Now for the APNA 33rd Annual Conference
Join your nursing community in New Orleans, Louisiana on October 2-5 to connect with your passion for the profession. Earn up to 123+ continuing education contact hours from cutting edge content. Register now!

Ketamine Infusion Therapy Resources
Online resources include a checklist providing considerations for prescribing or providing care to persons undergoing ketamine infusion therapy. Click here to access the resources.

Resources for Responding to Traumatic Events
In the wake of the recent tragedies in Texas and Ohio, resources are available for responding to traumatic events. At the bottom of the Resources for Responding to Traumatic Events page there is a section where you can also post comments and suggest resources to share with your community. Click here to access the resources.

Prepare for your ANCC Certification with ANA Review Courses!
The American Nurses Association Psychiatric-Mental Health Nursing and Psychiatric-Mental Health Nurse Practitioner Certification Review Courses provide information relevant to current practice and review materials to prepare for the ANCC Psychiatric-Mental Health Nursing and Psychiatric-Mental Health NP board certification exam. Learn more by clicking here. ANA Nonmember Discount Code: APNA-10OFF Registration closes Sept. 5, 2019.

The University of California, Berkeley has received a five-year grant expected to total $47 million from the U.S. National Institute on Aging (NIA) to incorporate advanced brain imaging into the Alzheimer’s Association’s groundbreaking clinical trial, the U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER), to determine whether lifestyle changes can protect memory in people at risk of developing dementia. The expanded study will be the first large-scale investigation of how lifestyle interventions, including exercise, diet, cognitive stimulation and health coaching, affect well-known biological markers of Alzheimer’s and dementia in the brain. Full Story

An international study has revealed specific sets of genes associated with the development of ADHD, autism spectrum disorder, bipolar disorder, major depression and schizophrenia, reported PsychCentral.com. Researchers analyzed more than 400,000 individuals to determine the genes behind these five mental health disorders. The finding is important as new pharmaceutical drugs could potentially target the shared pathways. Full Story

Drugmaker Eli Lilly said early results from a study suggest that Apple Inc devices, including the iPhone, in combination with digital apps could differentiate people with mild Alzheimer’s disease dementia and those without symptoms, according to a Reuters report. Full Story

Providers Clinical Support System (PCSS) is hosting three round table discussion sessions on Naltrexone. These one-hour discussions are designed to support interactions among experts and health professionals in the field through an informal "round table" conversation. All attendees are asked to submit questions or a case study prior to the discussion. Click here to learn more or register.

"Deep" repetitive transcranial magnetic stimulation (rTMS) plus standard antidepressant medication is significantly more effective at reducing depression levels in patients with major depressive disorder (MDD) than standard rTMS or stand-alone pharmacotherapy, new research suggests, reported MedScape. Full Story

The U.S. Department of Health and Human Services (HHS) through the Health Resources and Services Administration (HRSA) awarded nearly $400 million to combat the nation’s opioid crisis. The investments will enable HRSA-funded community health centers, rural organizations and academic institutions to establish and expand access to integrated substance use disorder and mental health services. Full Story

The number of individuals reporting pain reliever misuse decreased by 11% between 2018 and 2017, with fewer than 10 million Americans now reporting misuse, according to the Substance Abuse and Mental Health Services Administration's 2018 National Survey on Drug Use and Health (NSDUH). The annual survey is the nation’s primary resource for data on mental health and substance use among Americans. Full Story To access the full report, click here.

A new study has found that restless legs syndrome is associated with a nearly tripled risk of suicide and self-harm, reported PsychCentral.com. Researchers at Penn State found that people with restless legs syndrome (RLS) had a 2.7-fold higher risk of suicide or self-harm, even when the researchers controlled for other conditions such as depression, insomnia, diabetes, and more. Full Story

The ANA Enterprise announced that Humana Inc. has joined the Healthy Nurse, Healthy Nation™ (HNHN) Grand Challenge as a sponsor committed to ANA Enterprise’s efforts to prioritize the health of America’s four million nurses. HNHN is an initiative of the ANA Enterprise, which is comprised of the American Nurses Association, the American Nurses Credentialing Center, and the American Nurses Foundation. The initiative engages more than 500 partner organizations and more than 100,000 participants to take action in five key areas - physical activity, rest, nutrition, quality of life, and safety - to transform the health of the nation by improving the health of nurses. Full Story

Hundreds of thousands of Michigan residents with a mental illness or substance-use disorder are untreated, a crisis compounded by a shortage of health professionals and treatment facilities, according to a report by Atlarum. All told, the study found nearly 670,000 residents with mental illness did not receive treatment and more than 500,000 with a substance use disorder were untreated. Full Story To access the full report click here.

The Department of Health and Human Services (HHS) announced proposed changes to the federal regulations governing the confidentiality of patient records created by federally-assisted substance use disorder treatment programs, known as 42 CFR Part 2. The proposed rule establishes important revisions that support coordinated care among providers that treat substance use disorder (SUD), while maintaining privacy safeguards for patients seeking treatment for SUD. The proposed rule is the first of four regulations that have been identified in HHS's Regulatory Sprint to Coordinated Care that seeks to promote value-based outcomes for patients by examining federal regulations that impede coordinated care among health providers. Full Story

Two Pennsylvania legislators are promoting a proposal to change the way thousands of the state’s most vulnerable people get services for mental illness and addiction treatment across the Commonwealth, reported PublicSource.org. At issue is how the state delivers health services to Medicaid recipients, and whether they should merge the program offering behavioral health services with a larger one that also offers physical healthcare services. Complementary bills in state House and Senate committees aim to eliminate Behavioral HealthChoices — a program led by the state but delivered at the county level in Pennsylvania. Full Story

The Centers for Medicare & Medicaid Services (CMS) released new guidance to states to promote proper use of prescription opioids by updating standard requirements for the Medicaid Drug Utilization Review (DUR) program. The Medicaid DUR program is a two-phase process that screens drug claims to help identify clinical misuse or abuse and examines claims data to identify patterns of abuse. Full Story

The American Psychiatric Nurses Association is Accredited with distinction as a provider of continuing nursing education by the
American Nurses Credentialing Center's Commission on Accreditation.